In CML, several studies found that serum levels of VEGF and HGF were significantly increased and correlated with white blood cell counts and serum LDH levels; one group concluded that high blood levels of HGF correlated with poor prognosis and survival [16,17]. This evidence concerns the gene VEGFA and chronic myelogenous leukemia, BCR-ABL1 positive.